Dispositivo medico Neuromark a radiofrequenza per il trattamento della rinite cronica.
| Date | Round | Amount |
|---|---|---|
| Feb 2026 | Series C An oversubscribed 62.5 million euro Series C for Neurent Medical led by MVM Partners with Sofinnova Partners, EQT Life Sciences, Atlantic Bridge, Fountain Healthcare and Enterprise Ireland. | $72.5M |
| Jan 2021 | Series B Galway medtech Neurent Medical raised a $25m Series B led by LSP, with Atlantic Bridge and Fountain Healthcare Partners, to fund US expansion. | $25M |